WHO Releases 2025-2026 Influenza Vaccine Recommendations

Today, the World Health Organization (WHO) announced its recommendations for the viral composition of influenza vaccines for the 2025-2026 season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day meeting on the Composition of Influenza Virus Vaccines, a meeting that is held 2 times per year.1 WHO […]
Adaptation of WHO AWaRe Classification Supports UK’s National Stewardship Priorities

WHO AWaRe Book Image credits: WHO A modified Delphi approach led to the development of a UK-adapted version of the WHO’s AWaRe (Access, Watch, Reserve) antibiotic classification, designed to align with national antimicrobial stewardship (AMS) priorities. This adaptation supports efforts to improve antibiotic use across primary and secondary care settings in the UK. In a […]
Cold sore discovery IDs unknown trigger for those annoying flare-ups

Scientists have a new target to prevent cold sores after University of Virginia School of Medicine researchers discovered an unexpected way the herpes virus re-activates in the body. The finding could also have important implications for genital herpes caused by the same virus. The discovery from UVA’s Anna Cliffe, PhD, and colleagues seems to defy […]
Communicable disease threats report, 22 – 28 February 2025, week 9

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 February and includes updates on Legionnaires’ disease, chikungunya, dengue, influenza A(H5N1), Ebola, unknown disease in DRC, poliomyelitis, and an overview of respiratory virus epidemiology in the EU/EEA. Source link
The 2024-2025 COVID-19 Vaccine Show Limited Efficacy in Adults

cdc logo: Image credit: CDC In this week’s Centers for Disease Control’s (CDC) Morbidity and Mortality Weekly Report, shows limited efficacy in preventing emergency department visits for adults and a better efficacy in immunocompromised adults. “Vaccine effectiveness (VE) of 2024–2025 COVID-19 vaccine was 33% against COVID-19–associated emergency department (ED) or urgent care (UC) visits among […]
How Porphyromonas gingivalis Evasion of Immune Detection May Fuel Systemic Diseases

Gabriel Nussbaum, MD, PhD Image credits: Isreal Cancer Research Fund Researchers have uncovered how Porphyromonas gingivalis, a bacterium linked to periodontitis, evades immune detection, leading to chronic infections and potentially contributing to serious systemic diseases like cardiovascular disease and Alzheimer’s. This discovery sheds light on the bacterium’s use of the CD47 protein, which sends a […]